Shijiang Deng Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

1/2019	Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein.
1/2018	Reciprocal loop of hypoxia-inducible factor-1α (HIF-1α) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.
1/2016	MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression.
12/2014	Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shijiang Deng Research Topics

Disease

4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 12/2014
3	Hypoxia (Hypoxemia) 01/2019 - 01/2016
3	Neoplasms (Cancer) 01/2018 - 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Carcinogenesis 01/2016
1	Chronic Pancreatitis 12/2014

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2016 - 12/2014
1	Biological ProductsIBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	Pyruvate KinaseIBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	VimentinIBA 01/2016
1	Histone Deacetylase 1IBA 01/2016
1	trichostatin A (A 300)IBA 01/2016